1-220787213-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_022746.4(MTARC1):​c.269G>A​(p.Arg90Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000282 in 1,418,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

MTARC1
NM_022746.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.42

Publications

1 publications found
Variant links:
Genes affected
MTARC1 (HGNC:26189): (mitochondrial amidoxime reducing component 1) Enables molybdenum ion binding activity; molybdopterin cofactor binding activity; and oxidoreductase activity, acting on other nitrogenous compounds as donors. Contributes to nitrite reductase (NO-forming) activity. Involved in cellular detoxification of nitrogen compound; nitrate metabolic process; and nitric oxide biosynthetic process. Located in mitochondrion. Part of nitric-oxide synthase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32009).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTARC1NM_022746.4 linkc.269G>A p.Arg90Gln missense_variant Exon 1 of 7 ENST00000366910.10 NP_073583.3 Q5VT66-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTARC1ENST00000366910.10 linkc.269G>A p.Arg90Gln missense_variant Exon 1 of 7 1 NM_022746.4 ENSP00000355877.5 Q5VT66-1
ENSG00000286231ENST00000651706.1 linkn.224G>A non_coding_transcript_exon_variant Exon 1 of 9 ENSP00000499157.1 A0A494C1P3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000173
AC:
3
AN:
173406
AF XY:
0.0000213
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000107
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000282
AC:
4
AN:
1418130
Hom.:
0
Cov.:
31
AF XY:
0.00000285
AC XY:
2
AN XY:
701946
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32112
American (AMR)
AF:
0.0000764
AC:
3
AN:
39286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25288
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36748
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80914
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5366
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1091206
Other (OTH)
AF:
0.0000171
AC:
1
AN:
58606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000256
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 17, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.269G>A (p.R90Q) alteration is located in exon 1 (coding exon 1) of the MARC1 gene. This alteration results from a G to A substitution at nucleotide position 269, causing the arginine (R) at amino acid position 90 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.010
T
Eigen
Benign
-0.011
Eigen_PC
Benign
0.0021
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.89
D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
3.4
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.070
Sift
Benign
0.10
T
Sift4G
Benign
0.14
T
Polyphen
0.95
P
Vest4
0.13
MutPred
0.63
Loss of MoRF binding (P = 0.0458);
MVP
0.44
MPC
0.22
ClinPred
0.62
D
GERP RS
4.0
PromoterAI
0.023
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.26
gMVP
0.52
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200908372; hg19: chr1-220960555; API